Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 02 Mar 2023 17:40 CET |
BANIMMO A | BANIMMO: Geconsolideerde resultaten 2022 | 35101010 Real Estate Holding and Development | Income |
| 02 Mar 2023 17:40 CET |
BANIMMO A | BANIMMO : Résultats consolidés 2022 | 35101010 Real Estate Holding and Development | Income |
| 02 Mar 2023 16:44 CET |
SHURGARD | 20230301 Shurgard to participate in the Citi 2023 Global Property CEO Conference | 35101010 Real Estate Holding and Development | Other subject |
| 02 Mar 2023 08:15 CET |
BEKAERT | Bekaert: Openbaarmaking transparantiekennisgeving | 55102010 Iron and Steel | Legal |
| 02 Mar 2023 08:15 CET |
BEKAERT | Bekaert: Publication transparency notification | 55102010 Iron and Steel | Legal |
| 02 Mar 2023 08:15 CET |
BEKAERT | Bekaert: Publication notification de transparence | 55102010 Iron and Steel | Legal |
| 02 Mar 2023 08:00 CET |
VAN DE VELDE | VAN DE VELDE : Annual results 2022 | 40204020 Clothing and Accessories | Other subject |
| 02 Mar 2023 08:00 CET |
VAN DE VELDE | VAN DE VELDE : Résultats annuels 2022 | 40204020 Clothing and Accessories | Other subject |
| 02 Mar 2023 08:00 CET |
VAN DE VELDE | VAN DE VELDE : Jaarresultaten 2022 | 40204020 Clothing and Accessories | Other subject |
| 02 Mar 2023 07:00 CET |
ARGENX SE | argenx Reports Full Year 2022 Financial Results and Provides Fourth Quarter Business Update | 20103010 Biotechnology | Other subject |
| 02 Mar 2023 07:00 CET |
BIOCARTIS | Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test | 20101025 Health Services | Other subject |
| 02 Mar 2023 07:00 CET |
AZELIS GROUP NV | Azelis Group NV: FY2022 Results: Strong Momentum Drives 70% Growth in Adjusted EBITA | 55201000 Chemicals: Diversified | Commercial results |
| 02 Mar 2023 07:00 CET |
ARGENX SE | argenx Announces Planned Transition of Chief Operating Officer | 20103010 Biotechnology | Other subject |
| 02 Mar 2023 07:00 CET |
BIOCARTIS | Persbericht Biocartis Group NV: Biocartis maakt de goedkeuring bekend van de 510(k) door de US FDA van de Idylla™ MSI Test | 20101025 Health Services | Other subject |
| 02 Mar 2023 07:00 CET |
AZELIS GROUP NV | Azelis Group NV: Resultaten 2022: Door sterk momentum 70% groei in aangepaste EBITA | 55201000 Chemicals: Diversified | Commercial results |
| 01 Mar 2023 18:08 CET |
GBL | GBL - Stemrechten en noemer - Situatie op 28 februari 2023 | 30202000 Diversified Financial Services | Corporate life |
| 01 Mar 2023 18:06 CET |
GBL | GBL - Droits de vote et dénominateur - Situation au 28 février 2023 | 30202000 Diversified Financial Services | Corporate life |
| 01 Mar 2023 18:05 CET |
GBL | GBL - Voting rights and denominator - Situation as at February 28, 2023 | 30202000 Diversified Financial Services | Corporate life |
| 01 Mar 2023 18:00 CET |
BIOSENIC | BioSenic SA: Information on the total number of voting rights and shares | 20103010 Biotechnology | Share history |
| 01 Mar 2023 18:00 CET |
BIOSENIC | BioSenic SA : Information relative au nombre total de droits de vote et d’actions | 20103010 Biotechnology | Share history |
| 01 Mar 2023 17:40 CET |
KBC ANCORA ord | Annonce du nombre total des droits de vote au 28 février 2023 | 30101010 Banks | Other subject |
| 01 Mar 2023 17:40 CET |
KBC ANCORA ord | Bekendmaking van het totaal aantal stemrechten per 28 februari 2023 | 30101010 Banks | Other subject |
| 01 Mar 2023 17:40 CET |
KBC ANCORA ord | Announcement of the total number of voting rights as at 28 February 2023 | 30101010 Banks | Other subject |
| 01 Mar 2023 17:36 CET |
CRESCENT | GEREGLEMENTEERDE INFORMATIE - Openbaarmaking over een transparantiekennisgeving (artikel 14, eerste lid, van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen) | 15101010 Telecommunications Equipment | Other subject |
| 01 Mar 2023 17:33 CET |
CRESCENT | REGULATED INFORMATION - Disclosure on a transparency notification (Article 14(1) of the Law of 2 May 2007 on disclosure of major shareholdings) | 15101010 Telecommunications Equipment | Other subject |
| 01 Mar 2023 08:45 CET |
SOLVAY | Solvay belicht innovatie en groeimogelijkheden in de markt van lucht- en ruimtevaart en defensie | 55201000 Chemicals: Diversified | Corporate life |
| 01 Mar 2023 08:45 CET |
SOLVAY | Solvay highlights innovation and growth opportunities in Aerospace & Defense market | 55201000 Chemicals: Diversified | Corporate life |
| 01 Mar 2023 08:45 CET |
SOLVAY | Solvay met en avant l'innovation et les opportunités de croissance de ses activités dans les secteurs de l'aérospatiale et de la défense | 55201000 Chemicals: Diversified | Corporate life |
| 01 Mar 2023 07:15 CET |
BEKAERT | Bekaert zet Inkoopprogramma Eigen Aandelen verder | 55102010 Iron and Steel | Legal |
| 01 Mar 2023 07:15 CET |
BEKAERT | Bekaert continues its Share Buyback Program | 55102010 Iron and Steel | Legal |
| 01 Mar 2023 07:15 CET |
BEKAERT | Bekaert poursuit son Programme de Rachat d'Actions | 55102010 Iron and Steel | Legal |
| 01 Mar 2023 07:02 CET |
BEKAERT | Bekaert: 2022 Full Year Results | 55102010 Iron and Steel | Sales |
| 01 Mar 2023 07:02 CET |
BEKAERT | Bekaert: Résultats annuels 2022 | 55102010 Iron and Steel | Sales |
| 01 Mar 2023 07:02 CET |
BEKAERT | Bekaert: Jaarresultaten 2022 | 55102010 Iron and Steel | Sales |
| 01 Mar 2023 07:00 CET |
ONTEX GROUP | Ontex results: Strong recovery in profitability in Q4, built on solid top-line momentum | 45201020 Personal Products | Income |
| 01 Mar 2023 07:00 CET |
BEKAERT | Bekaert annonce la cession de ses activités Steel Wire Solutions au Chili et au Pérou | 55102010 Iron and Steel | Mergers, Acquiqitions, Transferts |
| 01 Mar 2023 07:00 CET |
CELYAD ONCOLOGY | Celyad Oncology: Letter to Shareholders | 20103010 Biotechnology | Corporate life |
| 01 Mar 2023 07:00 CET |
ONTEX GROUP | Ontex resultaten: Sterk herstel van winstgevendheid in het vierde kwartaal, ondersteund door stevige omzetgroei | 45201020 Personal Products | Income |
| 01 Mar 2023 07:00 CET |
BEKAERT | Bekaert kondigt verkoop aan van Staaldraad-toepassingsactiviteiten in Chili en Peru | 55102010 Iron and Steel | Mergers, Acquiqitions, Transferts |
| 01 Mar 2023 07:00 CET |
CELYAD ONCOLOGY | Celyad Oncology : Lettre aux Actionnaires | 20103010 Biotechnology | Corporate life |
| 01 Mar 2023 07:00 CET |
BEKAERT | Bekaert announces the sale of its Steel Wire Solutions businesses in Chile and Peru | 55102010 Iron and Steel | Mergers, Acquiqitions, Transferts |
| 28 Feb 2023 22:30 CET |
MDXHEALTH | MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference | 20103010 Biotechnology | Meetings / events |
| 28 Feb 2023 18:00 CET |
VGP | VGP NV: Voting Rights and Denominator | 35101010 Real Estate Holding and Development | Change in Capital |
| 28 Feb 2023 18:00 CET |
VGP | VGP NV: Stemrechten en Noemer | 35101010 Real Estate Holding and Development | Change in Capital |
| 28 Feb 2023 18:00 CET |
VAN DE VELDE | VAN DE VELDE : Inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
| 28 Feb 2023 18:00 CET |
VAN DE VELDE | VAN DE VELDE : Acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
| 28 Feb 2023 17:55 CET |
BIOCARTIS | Persbericht Biocartis Group NV: Openbaarmaking van uitstaande stemrechtverlenende effecten | 20101025 Health Services | Other subject |
| 28 Feb 2023 17:55 CET |
BIOCARTIS | Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities | 20101025 Health Services | Other subject |
| 28 Feb 2023 15:00 CET |
ECONOCOM GROUP | ECONOCOM: Notice of an Ordinary General Meeting and an Extraordinary General Meeting to be held on 31 March 2023 | 10101010 Computer Services | Legal |
| 28 Feb 2023 15:00 CET |
ECONOCOM GROUP | ECONOCOM: Convocation d'une Assemblée Générale Ordinaire et d'une Assemblée Générale Extraordinaire pour le 31 mars 2023 | 10101010 Computer Services | Legal |